echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > STING agonist to block the new coronavirus in the body's first line of defense shows the potential to prevent infection

    STING agonist to block the new coronavirus in the body's first line of defense shows the potential to prevent infection

    • Last Update: 2021-06-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    When the new coronavirus invades the human body, the first line of defense that needs to be crossed is usually the epithelial cells of the respiratory tract and alveoli.


    In the first study, the research team of the University of Pennsylvania found that the new coronavirus can avoid the production of activated interferon (IFN) in an in vitro culture experiment of human respiratory cells.


    Then, the research team tested the effect of a powerful STING activator called diABZI in two different mouse models of new coronavirus infection.


    In the second study, the research team from the University of Massachusetts Medical School and GlaxoSmithKline (GlaxoSmithKline) tested another variant of diABZI in a mouse model infected with the new coronavirus.


    In future work, the two research teams will work to determine the appropriate dosage and administration method of diABZI in humans, and to prove whether lung-targeted therapy can also be used to treat other respiratory pathogens, including influenza.


    Reference materials:

    [1] Li, M.


    [2] Humphries, F.


    [3] SARS-CoV-2 Gets a STING From Diaminobenzimidazoles.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.